Intermittent fasting (IF) has moved from niche biohacking territory into mainstream wellness culture, and for good reason — the evidence base supporting its metabolic, cellular, and potentially longevity-related benefits has grown considerably over the past two decades. But the conversation around it is often polarised: either extravagant claims about reversing ageing, or dismissal as just another calorie restriction rebranding. The reality, as usual, is more nuanced and more genuinely interesting than either extreme. This article examines what intermittent fasting actually does, what the research shows, who is most likely to benefit, and what the legitimate limitations are.
What Is Intermittent Fasting?
Intermittent fasting is not a diet in the conventional sense — it does not prescribe what you eat, only when. It encompasses several distinct protocols, each with different characteristics and evidence profiles:
- Time-restricted eating (TRE) / 16:8 — the most widely practiced approach; all food is consumed within an 8-hour window (commonly noon to 8pm), with a 16-hour fast covering the remaining day. This typically includes the overnight sleeping fast and simply extends it somewhat in both directions.
- 5:2 protocol — five days of normal eating alternated with two non-consecutive days of significant caloric restriction (typically 500–600 kcal), rather than complete fasting. Research on this protocol is substantial.
- Alternate day fasting (ADF) — full or near-complete fasting every other day. The most studied protocol in terms of metabolic outcomes, though the least practical for most people.
- Eat-Stop-Eat — one or two 24-hour complete fasts per week, with normal eating on remaining days.
The mechanistic effects of fasting are largely time-dependent and appear once glycogen stores are depleted and the body transitions to fat oxidation as its primary fuel source — a process that typically begins 12–16 hours into a fast, depending on metabolic rate, prior meal composition, and activity level.
What Happens in the Body During a Fast?
Understanding the physiological cascade that occurs during fasting helps contextualise why the effects of IF extend beyond simple calorie reduction. The key processes include:
Glycogen Depletion and Metabolic Switching
After the last meal, blood glucose and insulin levels decline as food-derived glucose is absorbed and stored. Liver glycogen is depleted over approximately 10–16 hours, at which point the liver begins producing ketone bodies from fatty acids. This metabolic shift — from glucose to fat and ketone oxidation — is associated with several physiological adaptations including improved insulin sensitivity, reduced inflammatory signalling, and changes in gene expression patterns related to stress resistance and cellular repair.
Autophagy: Cellular Housekeeping
Autophagy (from Greek: "self-eating") is a highly regulated cellular process in which cells break down and recycle damaged, misfolded, or dysfunctional proteins and organelles. It is one of the body's primary quality-control mechanisms and is powerfully upregulated by fasting. The 2016 Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi specifically for his work characterising the mechanisms of autophagy, which brought enormous scientific attention to fasting's cellular biology.
Reduced autophagy is associated with the accumulation of cellular debris implicated in neurodegeneration, cancer, infection susceptibility, and accelerated ageing. Fasting-induced autophagy is believed to be one of the primary mechanisms through which caloric restriction confers longevity benefits in animal studies — though direct quantification of autophagy induction and its clinical significance in humans remains an active area of research.
Hormonal and Inflammatory Changes
During fasting, insulin drops while glucagon, adrenaline, and growth hormone rise — a hormonal environment that promotes fat mobilisation, protein sparing, and metabolic flexibility. Inflammatory markers including CRP, IL-6, and TNF-alpha are consistently reduced in studies of both intermittent and prolonged fasting. BDNF (brain-derived neurotrophic factor), which supports neuronal health and cognitive function, is increased by caloric restriction and fasting in animal models and appears to be upregulated in humans as well.
Evidence-Based Benefits: What the Research Shows
Weight Loss and Body Composition
The most practically studied outcome is weight management. Intermittent fasting produces weight loss primarily through caloric reduction — the restricted eating window or fasting days naturally limit total intake for most people. Meta-analyses comparing IF to continuous caloric restriction find roughly equivalent weight loss outcomes over 6–12 months, which is actually a meaningful finding: IF is not superior to traditional caloric restriction for weight loss, but it is a valid alternative that some people find more sustainable and psychologically easier to maintain.
Where IF may have a slight advantage over simple caloric restriction is in body composition — several studies suggest proportionally greater fat loss (particularly visceral fat) with equivalent or better preservation of lean mass, particularly when combined with resistance exercise.
Insulin Sensitivity and Metabolic Health
The insulin-sensitising effects of fasting are among the most consistently demonstrated outcomes. Fasting periods allow insulin levels to fall, which improves cellular insulin receptor responsiveness over time. Studies in people with prediabetes and metabolic syndrome show meaningful improvements in fasting glucose, HbA1c (a marker of average blood glucose over 3 months), and insulin resistance indices with IF protocols. These effects appear independent of weight loss, suggesting a specific metabolic benefit beyond calorie reduction.
Cardiovascular Risk Markers
Multiple controlled trials have found reductions in triglycerides, LDL cholesterol, and blood pressure with IF, alongside improvements in the LDL particle size profile (smaller, denser LDL particles are more atherogenic — IF tends to shift this toward larger, less damaging particles). The combination of these effects represents a meaningful reduction in cardiovascular risk profile over time.
Longevity and Ageing: Promising but Preliminary in Humans
The most compelling evidence for IF's longevity effects comes from animal models, where caloric restriction consistently extends lifespan by 20–50% across a wide range of species. The translation to humans is plausible based on shared cellular mechanisms (autophagy, AMPK activation, mTOR inhibition, sirtuin upregulation) but has not been demonstrated directly — human lifespan studies are inherently impossible to conduct in the traditional trial format.
What we do have in humans are biomarker studies showing improvements in markers associated with ageing and age-related disease, and epidemiological evidence from populations with naturally occurring dietary restriction patterns. The longevity claim for IF is scientifically plausible and mechanistically well-supported, but appropriately described as promising rather than proven in humans.
[tip:Ramadan fasting — a naturally occurring month-long intermittent fast (no food or drink from sunrise to sunset) practiced by approximately 1.8 billion people annually — provides a unique observational dataset. Studies conducted in Ramadan consistently show reductions in blood glucose, cholesterol, inflammatory markers, and oxidative stress, despite the altered sleep patterns and timing of eating. This real-world evidence substantially supports the metabolic benefits of IF.]Who May Benefit Most?
Based on the available evidence, intermittent fasting is most likely to be beneficial for:
- People with insulin resistance, prediabetes, or metabolic syndrome
- Those who prefer structured eating windows over calorie counting
- People who regularly skip breakfast or are not hungry in the morning (16:8 often aligns with natural appetite patterns)
- Individuals looking for a sustainable long-term dietary framework rather than a short-term intervention
- Those with an interest in cellular health, inflammation reduction, and longevity-adjacent outcomes
Contraindications and Legitimate Cautions
Intermittent fasting is not appropriate for everyone, and several groups should avoid it or approach it only with medical supervision:
- Pregnant and breastfeeding women — caloric and nutrient demands during pregnancy and lactation are not compatible with fasting protocols.
- People with a history of eating disorders — restricted eating windows can reinforce disordered eating patterns and should be avoided or only undertaken with clinical support.
- People with type 1 diabetes or insulin-dependent type 2 diabetes — fasting creates significant glycaemic variability that requires close medical management; medication adjustment is typically necessary.
- People who are underweight or nutritionally depleted — further caloric restriction is contraindicated.
- Children and adolescents — growth and development require consistent nutrition; fasting is not recommended.
- People on certain medications — drugs that need to be taken with food, or that affect blood glucose, may require timing adjustment.
A common practical pitfall is using the eating window as licence to overeat or consume lower-quality food. IF is not a bypass of caloric balance or nutritional quality — the benefits depend on the overall dietary pattern, not just the timing.
[warning:If you have type 1 or insulin-dependent type 2 diabetes, or take medications that affect blood glucose, consult your doctor before starting any fasting protocol. Significant hypoglycaemia can occur if medication doses are not adjusted to account for fasting periods. Do not attempt fasting without medical guidance in these situations.]Supplements During Intermittent Fasting
A common question is whether supplements can enhance the benefits of fasting or support the body during fasting periods. A few are worth highlighting.
Berberine is a plant alkaloid that activates AMPK — the same cellular energy-sensing enzyme activated by fasting and caloric restriction. It has been shown in multiple clinical trials to improve insulin sensitivity and glucose metabolism by a mechanism comparable in some studies to metformin. For those practising IF for metabolic health reasons, berberine's AMPK-activating action is thematically complementary, making it one of the most rationally chosen supplements alongside a fasting protocol. Our metabolic health collection includes a range of berberine products from established brands:
[products:aliness-berberine-sulphate-99-400-mg-60-capsules, hepatica-berberine-sulphate-premium-400-mg-60-capsules, swanson-berberine-400-mg-60-capsules, aura-herbals-berberine-berberis-aristata-500-mg-60-capsules, vitaler-s-berberine-400-mg-60-capsules]Resveratrol and other polyphenol antioxidants activate sirtuins — a family of proteins involved in cellular stress responses, DNA repair, and longevity signalling pathways that overlap significantly with those activated by fasting. NAC (N-acetyl cysteine) supports glutathione synthesis and autophagy. Alpha-lipoic acid is a potent mitochondrial antioxidant that supports metabolic function during fasting. Together with resveratrol, these compounds are among the most-discussed supplements in the longevity and fasting context. Explore our antioxidants collection:
[products:solgar-resveratrol-250-mg-with-red-wine-extract-30-softgels, swanson-resveratrol-complex-180-mg-60-capsules, now-foods-nac-n-acetyl-cysteine-600-mg-100-veg-capsules, swanson-alpha-lipoic-acid-600-mg-60-capsules, now-foods-alpha-lipoic-acid-100-mg-60-veg-capsules, now-foods-nadh-10-mg-60-veg-capsules]Practical Starting Points for Intermittent Fasting
For those new to IF, the 16:8 time-restricted eating approach is the most accessible and the one with the least disruption to daily life. A practical starting approach:
- Begin with a 12-hour overnight fast (10pm to 10am, for example) and extend gradually as the pattern feels comfortable.
- Prioritise nutritional quality within the eating window — high protein, abundant vegetables, healthy fats, and minimally processed carbohydrates.
- Stay well-hydrated during the fasting period — water, plain herbal tea, and black coffee or tea (without milk or sweeteners) do not break a metabolic fast and are appropriate.
- Expect an adaptation period of 2–4 weeks during which hunger, energy, and mood may fluctuate before stabilising.
- Monitor how you feel — the goal is not endurance of discomfort but a sustainable pattern that fits your life. If you feel consistently unwell, lightheaded, or are unable to function normally, adjust the protocol or consult a healthcare professional.
